1 Linnenberg HS, Pfyffer GE, Brändli O. Multiresistente Tuberkulose in der Zürcher Höhenklinik Wald von 1984 bis 1992. Schweiz Rundschau Prax. 1993;82(40):1096–100.
2 Diacon AH, Pym A, Grobusch MP, de los Rios JM, Gotuzzo E, Vasilyeva I, et al. Multidrug-resistant tuberculosis and culture conversion with bedaquiline. N Engl J Med. 2014;371(8):723–32.
3 Lupien A, Vocat A, Foo CS, Blattes E, Gillon JY, Makarov V, et al. Optimized Background Regimen for Treatment of Active Tuberculosis with the Next-Generation Benzothiazinone Macozinone (PBTZ169). Antimicrob Agents Chemother. 2018;62(11):e00840-18.
5 Conradie F, Diacon AH, Ngubane N, Howell P, Everitt D, Crook AM, et al. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis. N Engl J Med. 2020;382(10):893–902.
6 Schluger NW. Prevention of Multidrug-resistant Tuberculosis in Close Contacts: Back to the Future? Am J Respir Crit Care Med. 2020;202(8):1077–78.
7 Kaelin M, Keller PM, Schoch OD, Günther G, Fehr J. Multiresistente Tuberkulose. Schweiz Med Forum. 2020;20(51–52):771–5.